Alucent Biomedical Funding: $60M Raised, Series B (2020)
Alucent Biomedical is based in Salt Lake City. It has raised $60M in total funding. Latest round: Series B.
Alucent Biomedical funding overview
Alucent Biomedical is based in Salt Lake City. Alucent Biomedical has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in October 2020. The round record for Alucent Biomedical runs through 2020; nothing later has been disclosed. Investors on record include Philips North America, Alumend, Fresenius. 3 distinct backers are named across the disclosed rounds.
Alucent Biomedical at a glance
Total raised
$60M
Latest round
Series B
Latest round date
October 2020
Headquarters
Salt Lake City
Notable investors
Philips North America, Alumend, Fresenius
Frequently asked about Alucent Biomedical funding
How much has Alucent Biomedical raised?
Alucent Biomedical has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Alucent Biomedical?
Philips North America, Alumend, Fresenius are named among the investors backing Alucent Biomedical.
What was the latest Alucent Biomedical funding round?
The most recent disclosed round is a Series B, announced in October 2020.
Where is Alucent Biomedical based?
Alucent Biomedical is based in Salt Lake City.
When did Alucent Biomedical last raise?
The last disclosed Alucent Biomedical round closed in October 2020 at Series B.
Totals shown for Alucent Biomedical aggregate every disclosed round on file. To see how that compares, browse the companies in Salt Lake City and the investors behind them below.
